This cholesterol drug is dropping from $14,600 to as low as $4,500
Regeneron and Sanofi announce rebate deal with benefit manager Express Scripts.
Markets Right Now: Stocks claw back losses, end mostly up
The latest on developments in financial markets (all times local): Stocks are opening moderately lower on Wall Street after several companies reported disappointing results.
Merck posts strong first-quarter profit, but revenue light
Merck is reporting strong profits for the first quarter, but revenue is just shy of what many had expected.
Pfizer's 1Q profit up 14 pct., sales just miss expectations
Pfizer is reporting strong first-quarter profits, but revenue is short of Wall Street expectations.
Sanofi, Regeneron to cut price of heart drug in Express Scripts deal
The drug, Praluent, dramatically lowers bad LDL cholesterol and reduces the risk of heart attacks and death in high-risk heart patients.
Merck posts 1Q beat, powered by Keytruda
Net income fell to $736 million, or 27 cents per share, in the first quarter from $1.55 billion, or 56 cents per share, a year earlier.
Pfizer tops profit estimates, driven by Prevnar sales
The largest U.S. drugmaker said on Tuesday net profit rose to $3.56 billion or 59 cents per share in the first quarter of 2018, from $3.12 billion or 51 cents per share a year earlier.
Recalls this week: ceiling fans, hard hats
More than 100,000 ceiling fans are being recalled because of faulty brackets connecting the fan blades.
Opioid crackdown leaving those who need them out in the cold?
America's opioid epidemic
New Chipotle CEO plans menu 'tweaks,' and maybe drive-thrus
Chipotle, which has been working to revive its business after past food safety scares, says a key sales figure rose as it increased prices in most of its restaurants.
‘Growing Pains’ actor Jeremy Miller credits alcoholism treatment
The implant was an “absolute game changer,” he says.
Medicare hospital prices could soon be posted for patients
CMS administrator Seema Verma said the regulation is part of the effort to make sure patients are put first in health care.
Actor Jeremy Miller on an implant to treat alcoholism
Implant to treat alcoholism
Stronger pound weighs on revenues at drugmaker GSK
Pharmaceutical and consumer goods maker GlaxoSmithKline says first-quarter revenue dropped 2 percent as a stronger pound offset encouraging sales of a new shingles treatment.
Drugmaker Takeda agrees to buy Shire for $64 billion
Japanese drugmaker Takeda has reached a tentative agreement to buy Ireland-based Shire Plc for 46 billion pounds ($64 billion) in one of the biggest pharma deals to date.
Global stocks slide, futures point to weak Wall Street open
Asian shares dipped Wednesday, mirroring a sell-off on Wall Street triggered by worries over slowing growth and falling profits.
Asian stocks slip following sell-off on Wall Street
U.S. stocks are higher Tuesday morning as investors applaud strong first-quarter results from companies including machinery maker Caterpillar, appliance maker Whirlpool and Fifth Third Bancorp.
Shire, Whirlpool rise while Caterpillar, 3M slide
Stocks that moved substantially or traded heavily Tuesday: Caterpillar Inc., down $9.55 to $144.44
First drug approved for most common inherited kidney disease
The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most common inherited kidney disease.
Audi recalls about 1.2M vehicles; coolant pumps can overheat
Audi is recalling about 391,000 cars and SUVs in the U.S. and Canada because the electric coolant pumps can overeat and possibly cause a fire.













